A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
Clinical trial NCT03207425 · COMPLETED
Trial details
- NCT number
- NCT03207425
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-14
- Primary completion
- 2017-09-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.